Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-12

First 12 Last

Share
Profile

Follow
Lucretious

6,566 Posts.

2012

03/02/22

11:18

Post #: 59324823
Share

Originally posted by Newbern: ↑

Guys, here in the US, Blue Star was just loaded onto the Schwab Global trading platform. This is one of the largest brokerages in this country. Tomorrow I will place an order as the potential for BNL is tremendous. I was not able to trade Blue Star as an OTC or Over The Counter in my retirement account. The irony is that BNL has one of the very best helium land packages in the US but difficult to trade here.

Currently I own some First Helium and Desert Mountain Energy; these are Canadian companies. Both are beginning to move into production. Neither have the 8% helium resource. First Helium though is harvesting oil from their wells to help pay for bringing up the helium.

Blue Star is in Colorado which has some of the most difficult environmental laws in the US to navigate through. I assume that is one reason for the two new partners along with various technical expertise and work crews. When I see the delayed accomplishments over the past year it doesn't bother me, just looking for progress This will be a long term hold for me.

The US has supplied 40% of worldwide helium until recently when the Federal helium repository in Texas began shutting down. This is a golden market for helium producers. Very few people here in the US know about helium or how to invest in helium explorers and producers. Most people have been investing in passive ETFs; this doesn't appear it will continue to work. There is a groundswell of investors beginning to move into commodities here in the US. In a year or two I bet Blue Star turns out to be an excellent investment.

Expand

I found this old August 2021 article on the matter re Texas, and though the article is about Desert Mountain, it is very relevant to the overall helium market.

Desert Mountain Energy: Let's Play Helium Tetris (DMEHF) | Seeking Alpha

More recent news in the general helium market suggests supply pressures and thus rising prices. BNL at these prices are attractive risk reward IMO

BNL Price at posting: 4.7¢ Sentiment: Buy Disclosure: Held
9 Upvote

1 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 12 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change -0.001(9.09%)		Mkt cap ! $13.47M

Open	High	Low	Value	Volume
0.5¢	0.6¢	0.5¢	$42.40K	8.442M

Buyers (Bids)

No.	Vol.	Price($)
24	22550660	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	426704	1

View Market Depth

No.	Vol.	Price($)
24	22550660	0.004
9	15476669	0.003
6	20032500	0.002
5	29805000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	426704	1
0.006	3074481	10
0.007	8056658	17
0.008	12112729	27
0.009	3930033	11

Last trade - 12.55pm 27/06/2025 (20 minute delay)

BNL (ASX) Chart

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-12

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-12

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News